FDA expands approval of Roche's bleeding disorder drug
Roche said on Thursday U.S. regulators approved its hemophilia A drug Hemlibra, expanding its use in nearly all patients, as the Swiss drugmaker pushes deeper into diseases beyond cancer to replace revenue from older, patent-expired drugs.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Bleeding | Cancer | Cancer & Oncology | Haemophilia | Health | Hemophilia | Switzerland Health